Close
ACHEMA MIDDLE EAST 2026

Studies suggest new key to ‘switching off’ hypertension

A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood...

New plan of attack in cancer fight

New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for...

Uncovering a healthier remedy for chronic pain

Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative. A Duke...

FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 9,600 websites...

FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers

The U.S. Food and Drug Administration announced that the U.S. is now a "listed" countrydisclaimer icon with the European Commission (EC) so that U.S....

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible...

Big multiple sclerosis breakthrough

A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...